Homologies entre les deux rétrovirus BLV et HTLV-1 et développement d'une nouvelle approche thérapeutique basée sur la levée de la latence virale

N. Gillet, R Kettmann, L. Willems

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs

Résumé

BLV (bovine leukemia virus) and HTLV-1 (human T-cell leukemia virus) are related retroviruses inducing leukemia (BLV and HTLV-1) or infl ammatory diseases (HTLV-1) in the bovine and the human species respectively. The diseases are characterized by an apparent lack of viral expression in many infected cells in vivo. A humoral and a cellular immune response directed against viral antigens is continuously present. In fact, these two viruses have developed a series of mechanisms tightly controlling their expression, thereby allowing escape from the immune surveillance. Among these, chromatin compaction plays an essential role in the transcriptional regulation of the virus. The level of chromatin compaction is the result of an interplay between antagonistic actions of two families of enzymes: HATs (histone acetyltransferases) and HDACs (histone deacetylases) which, respectively, incorporate or withdraw histone acetyl groups. HDAC inhibitors induce a decondensation of chromatin and consequently increase the transcription. Thus, latent infected cells are forced to express viral proteins and are destroyed by the immune response. This viral gene activation therapy might be a novel approach for the treatment of BLV and HTLV-1 induced diseases.
Titre traduit de la contributionHomologies between BLV and HTLV-1 retroviruses and development of a novel therapeutic
langue originaleFrançais
Pages (de - à)155-163
Nombre de pages9
journalBiotechnologie, Agronomie, Société et Environnement
Volume11
Numéro de publication2
Etat de la publicationPublié - 2007
Modification externeOui

mots-clés

  • Sciences de la santé humaine => Oncologie

Empreinte digitale

Examiner les sujets de recherche de « Homologies entre les deux rétrovirus BLV et HTLV-1 et développement d'une nouvelle approche thérapeutique basée sur la levée de la latence virale ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation